Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome.

The article focuses on a randomized trial BIOMArCS-2 Glucose which was conducted to evaluate the effect of using intensive glucose control (IGC) in myocardial infarction (MI). Topics discussed include no association between use of IGC in hyperglycemic MI patients and improved outcomes, lowering blood glucose in hyperglycemic causes excess mortality and risk of higher mortality during long term follow-up.